AbbVie's Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert

AbbVie recently filed a patent infringement lawsuit against BeiGene over their blockbuster BTK franchises. Although the litigation was launched right after a patent’s issuance, AbbVie may actually have a case here, according to one expert.